Skip to main content
Log in

Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women

  • Orignial Articles
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

We evaluated the influence of continual estrogen replacement therapy (ERT) as presently practiced by postmenopausal women with conjugated estrogens and medroxyprogesterone acetate (MPA) on the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis and cellular immunity. Thirty-nine postmenopausal women were evaluated (12 on no replacement, 14 on estrogen only, and 13 on estrogen and MPA). In the women receiving only conjugated estrogens, increased GH levels and decreased IGF-1 levels were found, which replicated previous research and probably reflected estrogen inhibition of hepatic IGF-1 production with a secondary increase in GH release because of reduced feedback inhibition. In women taking both MPA and estrogen, GH was increased and the previously observed estrogen induced decrease in IGF-1 levels was inhibited.

In order to determine the influence of ERT on psychosocial stress-induced GH release, math (mental stress) and speech (social stress) challenges were utilized, and they produced significant increases in heart rate in all three groups. The heart rate following stress was significantly enhanced by estrogen replacement. These stressors also led to increased GH secretion in the women taking estrogen and MPA, but not in the other two groups.

Gonadal steroids and GH can influence cellular immunity. We observed that ERT in both groups was associated with significantly enhanced lymphocyte responsiveness to the T-cell mitogens phytohemaglutinin (PHA) and Conconavalin A (Con A), and basal GH levels were correlated with the PHA response in the estrogen only group. ERT did not influence natural killer (NK) cell activity. We also found significant differences in the steady-state expression of latent Epstein-Barr virus (EBV) with increased antibody titers in the women in the estrogen only group and lower antibody titers in the MPA plus estrogen group. GH levels were correlated with EBV antibody titers in the estrogen plus MPA group.

This study supports the hypothesis that GH and immune modulation can be influenced by ERT in postmenopausal woman. Given the extant literature on the immune-enhancing effects of GH, these data suggest that ERT may slow the declien of GH secretion with aging, an event that has been implicated in immunosenescence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ho, K. Y., Evans, W. S., Blizzard, R. M., Veldhuis, J. D., Merriam, G. R., Samojlik, E., et al. (1987).J. Clin. Endocrinol. Metab. 64, 511–518.

    Google Scholar 

  2. O’Keane, V. and Dinan, T. G. (1992).J. Clin. Endocrinol. Metab. 75, 11–14.

    Article  PubMed  CAS  Google Scholar 

  3. Marin, G., Domene, H. M., Barnes, K. M., Blackwell, B. J., Cassorla, F. G., and Cutler, G. B., Jr. (1994).J. Clin. Endocrinol. Metab. 79, 537–541.

    Article  PubMed  CAS  Google Scholar 

  4. Dawson-Hughes, B., Stern, D., Goldman, J., and Reichlin, S. (1986).J. Clin. Endocrinol. Metab. 63, 242–432.

    Article  Google Scholar 

  5. Weissberger, A. J., Ho, K. K. Y., and Lazarus, L. (1991).J. Clin. Endocrinol. Metab. 72, 374–381.

    PubMed  CAS  Google Scholar 

  6. Friend, K. E., Hartman, M. L., Pezzoli, S. S., Clasey, J. L., and Thorner, M. O. (1996).J. Clin. Endocrinol. Metab. 81, 2250–2256.

    Article  PubMed  CAS  Google Scholar 

  7. Bellantoni, M. F., Vittone, J., Campfield, A. T., Bass, K. M., Harman, S. M., and Blackman, M. R. (1996).J. Clin. Endocrinol. Metab. 81, 2848–2853.

    Article  PubMed  CAS  Google Scholar 

  8. Malarkey, W. B. and Daughaday, W. H. (1972).Endocrinology 90, 909–914.

    PubMed  CAS  Google Scholar 

  9. Malarkey, W. B. and Daughaday, W. H. (1971).J. Clin. Endocrinol. Metal. 33, 424–431.

    Google Scholar 

  10. Bellatoni, M. F., Harman, S. M., Cho, D. E., and Blackman, M. R. (1991).J. Clin. Endocrinol. Metab. 72, 172–178.

    Google Scholar 

  11. Malarkey, W. B., Hall, J. C., Pearl, D. K., Kiecolt-Glaser, J. K., and Glaser, R. (1991).J. Clin Endocrinol. Metab. 73, 1089–1092.

    PubMed  CAS  Google Scholar 

  12. Malarkey, W. B., Kiecolt-Glaser, J. K., Pearl, D., and Glaser, R. (1994).Psychosom. Med. 56, 41–51.

    PubMed  CAS  Google Scholar 

  13. Olsen, N. J. and Kovacs, W. J. (1996).Endocr. Rev. 17, 369–384.

    Article  PubMed  CAS  Google Scholar 

  14. Berczi, I. (1994).Neuroimmunomodulation 1, 201–216.

    Article  PubMed  CAS  Google Scholar 

  15. Glaser, R. and Kiecolt-Glaser, J. K. (1994). In:Human Herpesvirus Infections, Glaser, R. and Jones, J. (eds.) Marcel Dekker, New York, pp. 245–270.

    Google Scholar 

  16. Malarkey, W. B., Wu, H., Cacioppo, J. T., Malarkey, K. L.. Poehlmann, K. M., Glaser, R., and Kiecolt-Glaser, J. K. (1996).Endocrine 5, 33–39.

    Article  CAS  Google Scholar 

  17. Kirschbaum, C., Schommer, N., Federenko, I., Gaab, J., Neumann, O., Oellers, M., et al. (1996).J. Endocrinol. Metab. 81, 3639–3643.

    Article  CAS  Google Scholar 

  18. Lindheim, S. R., Legro, R. S., Bernstein, L., Stanczyk, F. Z., Vijod, M. A., Presser, S. C., and Lobo, R. A. (1992).Am. J. Obstet. Gynecol. 167, 1831–1836.

    PubMed  CAS  Google Scholar 

  19. Del Rio, G., Velardo, A, Zizzo, G., Avogaro, A., Cipolli, C., Della Casa, L., et al. (1994).J. Clin. Endocrinol. Metab. 79, 836–840.

    Article  PubMed  Google Scholar 

  20. Rosner, W. (1990).Endocr. Rev. 11, 80–91.

    PubMed  CAS  Google Scholar 

  21. Murphy, L. J. and Friesen, H. G. (1988).Endocrinology 122, 325–332.

    PubMed  CAS  Google Scholar 

  22. Friend, K. E., Chiou, Y. K., Lopes, M. B. S., Laws, E. R., Jr., Hughes, K. M., and Shupnik, M. A. (1994).J. Clin. Endocrinol. Metab. 78, 1497–1504.

    Article  PubMed  CAS  Google Scholar 

  23. Chowen, J. A., Garcia-Segura, L. J., Gonzalez-Parra, S., and Argente, J. (1996).Cell. Mol. Neurobiol. 16, 297–310.

    Article  PubMed  CAS  Google Scholar 

  24. Sgoutas-Emch, S. A., Cacioppo, J. T., Uchino, B. N., Malarkey, W., Pearl, D., Kiecolt-Glaser, J. K., and Glaser R. (1994).Psychophysiology 31, 264–271.

    Article  PubMed  CAS  Google Scholar 

  25. Cacioppo, J. T., Malarkey, W. B., Kiecolt-Glaser, J. K., Uchino, B. N., Sgoutas-Emch, S. A., Sheridan, J. F., et al. (1995).Psychosom. Med. 57, 154–164.

    PubMed  CAS  Google Scholar 

  26. Kooijman, R., Hooghe-Peters, E. L., and Hooghe, R. (1996).Adv. Immunol. 63, 377–454.

    Article  PubMed  CAS  Google Scholar 

  27. Van Voorhis, B. J., Anderson, D. J., and Hill, J. A. (1989).J. Clin. Endocrinol. Metab. 69, 1195–1199.

    PubMed  Google Scholar 

  28. Gray, J., Wreghitt, T. G., Pavel, P., Smyth, R. L., Parameshwar, J., Stewart, S., et al. (1995).J. Heart Lung Transplantation 14, 640–646.

    CAS  Google Scholar 

  29. Kelley, K. W., Arkins, S., Minshall, C., Liu, Q., and Dantzer, R. (1996).Horm. Res. 45, 38–45.

    PubMed  CAS  Google Scholar 

  30. Saab, P. G., Matthews, K. A., Stoney, C. M., and McDonald, R. J. (1989).Psychophysiology 25, 270–280.

    Article  Google Scholar 

  31. Glaser, R., Rice, J., Speicher, C. E., Stout, J. C., and Kiecolt-Glaser, J. K. (1986).Behav. Neurosci. 100, 675–678.

    Article  PubMed  CAS  Google Scholar 

  32. Kazimer, R. M., Whisler, R. L., Stephens, R. E., Pearl, D. K., and Yates, A. J. (1989).J. Neurooncol. 7, 145–150.

    Article  PubMed  CAS  Google Scholar 

  33. Glaser, R. G., Strain, E. C., Tarr, K. L., Holliday, J. E., Donnerberg, R. L., and Kiecolt-Glaser, J. K. (1985).Proc. Soc. Exp. Biol. Med.,179, 352–355.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to William B. Malarkey MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Malarkey, W.B., Burleson, M., Cacioppo, J.T. et al. Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women. Endocr 7, 227–233 (1997). https://doi.org/10.1007/BF02778145

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02778145

Key Words

Navigation